zklaassen_md Profile Banner
Zach Klaassen Profile
Zach Klaassen

@zklaassen_md

Followers
4K
Following
23K
Media
1K
Statuses
9K

Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor

Augusta, GA
Joined July 2013
Don't wanna be here? Send us removal request.
@zklaassen_md
Zach Klaassen
2 years
Honestly, the emails, texts, DMs, etc are what make this recognition so special. I don't know what one has to do to get this award, but I'm grateful to @AmerUrological @SES_AUA for the nomination. All I can say is (in no particular order): 1) Be better each day, 2) Mentor/teach.
@AmerUrological
Amer. Urol. Assn.
2 years
Congratulations to the 2023 Young Urologist of the Year Award Winners! Join us in congratulating these early-career urologists and their commitment to advancing the specialty! Read more here ➑️ #AUA #Urology #AUAMembers
Tweet media one
Tweet media two
20
12
184
@zklaassen_md
Zach Klaassen
3 years
mCRPC management is influenced by the treatments received in previous lines . Excellent algorithm from @Ecastromarcos -- likely to change with PSMA RLT. @urotoday #EAU22
Tweet media one
2
53
154
@zklaassen_md
Zach Klaassen
5 months
The honesty, thoughtfulness, and wit of @ChrisSweens1 . Phase 3 trials of Immunotherapy in Prostate Cancer -- .A Case Study of "Failed All-Comer Strategy". ⚑️8 negative trials.πŸ’° >$700 million USD.πŸ‘¨β€πŸ¦° 7,305 patients. #ESMO24 @urotoday
Tweet media one
2
46
145
@zklaassen_md
Zach Klaassen
5 years
Such a humbling honor to take over the @mcg_urology residency program. A program that gave me exceptional training & one that I was fortunate to rejoin after fellowship. Big shoes to fill! @mkterris has done an amazing job the last 15+ years. Yes, @DelaigleKim is INCREDIBLE.
@mcg_urology
MCG Urology
5 years
Congratulations to new MCG Urology Residency Program Director, Dr. Zach Klaassen. Along with our extraordinary Program Coordinator Kim Maddox, Dr. Klaassen will keep our program going strong! .@zklaassen_md @DelaigleKim #UroMasters
Tweet media one
19
8
142
@zklaassen_md
Zach Klaassen
5 years
Humbled, honored, and extremely grateful to be named the "Ronald W. Lewis, MD Endowed Chair for Urologic Education". Professor Emeritus Dr. Lewis leaves an incredible legacy of resident education that I can only hope to live up to. These pictures will be in my office forever.
@mcg_urology
MCG Urology
5 years
Witherington Chair of Urology @mkterris announcing Professor Emeritus Dr. Ron Lewis' "Ronald W. Lewis, MD Endowed Chair in Urologic Education" for @zklaassen_md
Tweet media one
Tweet media two
Tweet media three
Tweet media four
30
7
134
@zklaassen_md
Zach Klaassen
5 years
So freaking happy and proud of my friend, colleague, mentor and boss @mkterris on her nomination to the American Association of Genitourinary Surgeons!.πŸ™ŒπŸ»βš‘πŸ…πŸŽ‰.@mcg_urology @MCG_Surgery @GACancerCenter @AUG_OFS @MCG_AUG @AUG_Health @AUG_JAGWIRE @GA_Urol_Assoc @SES_AUA @SWIUorg
Tweet media one
21
6
120
@zklaassen_md
Zach Klaassen
2 years
Going to be an incredible year. The first DEPARTMENT of Urology Residency class 2023-2024. @mcg_urology @MCG_AUG
Tweet media one
6
11
115
@zklaassen_md
Zach Klaassen
6 years
We DO know how BCG works! . Great slide from @BrantInman .#AUA19 #SBUR19 #SUO19 .@SUO_YUO
Tweet media one
3
55
103
@zklaassen_md
Zach Klaassen
5 years
Big win for #prostatecancer and #mentalhealth today: still somewhat speechless and incredibly grateful for the @DeptofDefense funding my grant looking at these entities in the national VINCI @DeptVetAffairs system. Great mentorship from @SFreedlandMD & @mkterris !.πŸ™πŸ‡ΊπŸ‡Έ
Tweet media one
6
3
87
@zklaassen_md
Zach Klaassen
4 years
Plenary Session @ASCO #ASCO21 . VISION: Ph 3 Lu-177 PSMA in pts with mCRPC. 🏷 2:1 randomization to 177-Lu PSMA + SOC vs SOC.🏷OS benefit 177-Lu PSMA 15.3 vs 11.3 mo (HR 0.62, 95% CI 0.52-0.74).🏷 rPFS benefit 177-Lu PSMA 8.7 vs 3.4 mo (HR 0.40, 95% CI 0.29-0.57).@urotoday
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
30
90
@zklaassen_md
Zach Klaassen
3 years
Huge congrats to our @mcg_urology Chair, my mentor, and friend @mkterris for an incredibly well deserved @AmerUrological Distinguished Service Award! . @IMRhelpsvets @AUG_OFS @MCG_Surgery
Tweet media one
7
10
88
@zklaassen_md
Zach Klaassen
5 years
AMAZING progress in metastatic urothelial carcinoma in the last 17 months!. Beautiful schematics and excellent discussant presentation from @TiansterZhang at #ASCO20 . @urotoday
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
39
84
@zklaassen_md
Zach Klaassen
5 years
First results of RADICALS (biochemical analysis) @PCaParker:. Biochemical PFS: no difference between adjuvant and salvage RT (HR 1.10, 95%CI 0.81-1.49). @urotoday #ESMO2019 #ESMO19
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
34
80
@zklaassen_md
Zach Klaassen
3 years
This is the kind of ingenuity we're lookin for at @mcg_urology . PGY-2 Kyle Cline with a great addition to the Coffee Station
Tweet media one
4
2
82
@zklaassen_md
Zach Klaassen
5 years
"When a surgeon designates a tumor β€œinoperable”, they do not mean that it is physically impossible to operate. They mean that, with careful analysis, the risks of operating outweigh the benefits". ROI: One of the most important lessons in surgery .#MedEd.
4
12
81
@zklaassen_md
Zach Klaassen
7 years
May have to fact check this, but pretty sure this is the first time @Eminem has been referenced at an @ASCO sanctioned event. Well done @ChrisSweens1 ! #GU18
Tweet media one
2
25
80
@zklaassen_md
Zach Klaassen
5 months
Promising biomarkers in mHSPC -- @NivenMehra . #ESMO24 @urotoday
Tweet media one
0
31
78
@zklaassen_md
Zach Klaassen
4 years
Dropped off my oldest at school this morning on her 13th birthday . Can't believe THAT just happened 😳. So proud of her - 7th grader doing 9th grade math and 8th grade pretty much everything else. Kind, loving, caring. Days are long and the weeks are short. (πŸ“·: a few weeks ago)
Tweet media one
3
0
72
@zklaassen_md
Zach Klaassen
5 months
#ESMO24 Congress Highlights - Prostate Cancer.@UrsulaVogl . Looking at the nuances: characteristics of the two phase 3 trials (SPLASH and PSMAfore) in the mCRPC taxane naive setting. @urotoday
Tweet media one
2
27
73
@zklaassen_md
Zach Klaassen
5 years
Congrats πŸ‘πŸΌ to @spsutkaMD -- Clinical decision aid to support treatment selection for patients with cT1 renal masses. 5-Yr CSM, OCM & 90-d Clavien 3-5 complications for pts selecting between RNx, PNx, thermal ablation & AS. #GU20 @urotoday
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
20
75
@zklaassen_md
Zach Klaassen
5 years
Moving into summer, traditional sub-I season.Applicants:.- Get on Twitter, be active.- Attend as many residency virtual open houses as you can. Many programs doing this across πŸ‡ΊπŸ‡Έ, s/o to a few in the @SES_AUA : @mcg_urology @emory_urology @VUMCurology @UNCurology @UF_Urology.
0
19
71
@zklaassen_md
Zach Klaassen
3 years
Optimal Dissemination of Scientific Manuscripts via SoMe: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in @EUplatinum . πŸ”‘Twitter impressions > for VAs vs KFs (8385 vs 6882, p = 0.006)
Tweet media one
6
16
73
@zklaassen_md
Zach Klaassen
6 years
Summary of PRECISION, MRI FIRST, and 4M studies from @mrsprostate -- @Uroweb #ESOU19 debate: mpMRI for all men with elevated PSA. Standard of care in the UK
Tweet media one
0
32
71
@zklaassen_md
Zach Klaassen
6 years
Results of TITAN released for @asco #ASCO19 :.Apa + ADT vs ADT alone for mCSPC. OS benefit for Apa: HR 0.67, 95%CI 0.51-0.89.11% of pts with prior docetaxel. Landscape is changing meeting to meeting .#prostatecancer.
1
26
69
@zklaassen_md
Zach Klaassen
4 years
Proud of my man @rksayyid matching in @UroOnc @UofTUrology today! πŸ‘Š. Coming full circle: we met in Toronto 2016 when I was a fellow and Rashid was a Masters student with @FleshnerNeil . (Second pic, circa Jan '17 in T.O. - @AmerUrological match day for Rashid into @mcg_urology )
Tweet media one
Tweet media two
6
3
70
@zklaassen_md
Zach Klaassen
3 years
We have come a long way in mHSPC:.2015: CHAARTED mOS 33 mos .2022: PEACE-1 mOS 61 mos. But, VA, SEER-Medicare, private insurance claims data suggests that ~45%-80% of men not receiving Rx intensification beyond ADT alone. Ongoing work to figure out why. #APCCC22 @urotoday
Tweet media one
0
22
71
@zklaassen_md
Zach Klaassen
6 years
Here we go - #TipsForNewDocs .1) Don't "Doctor" your colleagues: Introduce yourself using first & last name, your service.2) Be humble .3) Own your mistakes - you'll make them. plenty of them .4) Teach the med students .5) Never cause your patient to lose hope.
4
22
66
@zklaassen_md
Zach Klaassen
5 years
Really appreciate everyone joining us for our first @mcg_urology Virtual Open House! .Peaked at 65 participants πŸ™ŒπŸ».Happy Memorial Day everyone πŸ‡ΊπŸ‡Έ.@Uro_Res
Tweet media one
5
6
67
@zklaassen_md
Zach Klaassen
5 years
Phase 3 Adjuvant Chemo for UTUC -- first presented at GU @ASCO '18, now published in @TheLancet. Adjuvant chemotherapy significantly improved DFS (HR 0.45, 95% CI 0.30–0.68; p=0.0001) at a median follow-up of 30.3 months.
3
32
67
@zklaassen_md
Zach Klaassen
2 years
Thank you πŸ™. But, more importantly, thank you for resurrecting this sweet pic from Movember 2019 🀣.
@AUG_JAGWIRE
JAGWIRE
2 years
The @AmerUrological has named @Zklaassen_md as a Young Urologist of the Year award winner!. πŸ”— Read more:
Tweet media one
4
7
68
@zklaassen_md
Zach Klaassen
5 years
One of my old partners is retiring and cleaning out his office -- he found a stack of these scrub cap relics. I feel more blood flow going to my head already 😳
Tweet media one
0
0
66
@zklaassen_md
Zach Klaassen
10 months
Lots of data upcoming in the oligometastatic mHSPC space . Trials from @ChrisSweens1 . #EAU24 @urotoday
Tweet media one
1
22
64
@zklaassen_md
Zach Klaassen
5 years
Merry Christmas from our crew to yours! #onesie #MerryChrismas .πŸŽ„πŸŽ…πŸ»
Tweet media one
2
2
59
@zklaassen_md
Zach Klaassen
3 years
Absolutely phenomenal lecture from @DrChoueiri in the @myESMO On Demand Educational Session discussing 1L treatment for mRCC. Attached algorithm: what he uses in the clinic when deciding 1L treatment approach for mRCC patients . Summary available soon on @urotoday #ESMO21
Tweet media one
1
20
60
@zklaassen_md
Zach Klaassen
2 years
So incredibly happy for and proud of @mkterris -- this has been overdue and in the making for a loooong time now. Tremendous persistence! . There's been 4 Division Chiefs over the 60+ years of our program, but only 1 Department of Urology Chair πŸ‘ŠπŸ˜.
@mcg_urology
MCG Urology
2 years
Announcement! We are grateful for the support and encouragement of our institution in attaining the goal of Department of Urology!
Tweet media one
3
5
61
@zklaassen_md
Zach Klaassen
5 years
Applicants applying to this year's @AmerUrological Residency Match: please encourage those applying that aren't on social media to join. Hard to reach applicants these days during #COVID19 that aren't on SM. brainstorming ideas #UroSoMe.@Uro_Res @mcg_urology @SES_AUA @mkterris.
1
22
58
@zklaassen_md
Zach Klaassen
4 years
School assignment for my 8 year old son - "Write something about #COVID19 ". This is COVID positivity
Tweet media one
1
0
58
@zklaassen_md
Zach Klaassen
4 years
What are the biggest intraop fallacy statements in Urology?. Here's one:. "You're MILES away from the rectum". #UroTwitter.
28
2
57
@zklaassen_md
Zach Klaassen
5 years
@LoebStacy This guy. killing it
Tweet media one
7
1
56
@zklaassen_md
Zach Klaassen
3 years
The 10-year history of PSMA radioligand therapy from Matthias Eiber. @urotoday #EAU22
Tweet media one
0
21
58
@zklaassen_md
Zach Klaassen
2 years
We are recruiting a Uro Onc to join our team at @mcg_urology @GACancerCenter. Augusta, GA and the CSRA: great place to live, raise a family, work w/ phenomenal partners & residents . If you're attending #SUO22 in San Diego and would like to meet to discuss, shoot me a DM!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
15
54
@zklaassen_md
Zach Klaassen
5 years
Hi, I'm a urologic oncologist. You may know me from my hits "that PSA of 3.9 at age 75 is not concerning", "no, the robot doesn't actually do the procedure", and the chart-topping "please drop your pants, place your chest flat on the table, and spread your legs slightly apart".
@scotter
Scott Sparks, MD
5 years
Hi, I’m a pediatric urologist. You may know me from my hits β€œthat’s not actually a UTI”, β€œno we don’t need an ultrasound to find your kid’s testis”, and the chart-topping β€œyou’re symptoms are probably due to constipation”.
2
4
55
@zklaassen_md
Zach Klaassen
5 years
Proton beam therapy for PCa?.
@nypost
New York Post
5 years
'Perineum sunning' is latest insanity wellness influencers swear by
Tweet media one
2
0
56
@zklaassen_md
Zach Klaassen
2 months
BCG Unresponsive Cancer in 2024 @UroDocAsh at the #SUO24 Bladder Cancer Course. Bladder-sparing therapy for BCR-UR NMBIC: @IBCG_BladderCA Recommendations for Optimal Sequencing and Patient Selection. @urotoday
Tweet media one
1
18
56
@zklaassen_md
Zach Klaassen
11 months
.@DrRanaMcKay 's practical approach to treating 1L clear cell mRCC in 2024. An effective clinic triage algorithm! . @urotoday #SoCalGU24
Tweet media one
1
23
56
@zklaassen_md
Zach Klaassen
5 years
#Urology colleagues in the Southeast: if you, your family, or patients need lodging this week during #HurricaneDorian our house is open and I'm on call for @mcg_urology at @AUG_Health all week.DM me.@SES_AUA @GA_Urol_Assoc.
1
9
55
@zklaassen_md
Zach Klaassen
5 years
MCG Urology Residents 2020-2021. Let's go!!! 😁.@mcg_urology @SES_AUA @AmerUrological @MCG_AUG
Tweet media one
1
5
53
@zklaassen_md
Zach Klaassen
1 year
#ESMO23 @DrChoueiri with an outstanding treatment algorithm for first-line mRCC. @urotoday
Tweet media one
1
23
52
@zklaassen_md
Zach Klaassen
1 year
A lot of moving parts in BCG-unresponsive NMIBC!. Updated table from @MarkTysonMD after presenting initial results of BOND-003. #SUO23 @urotoday
Tweet media one
1
13
49
@zklaassen_md
Zach Klaassen
3 years
#ASCO22 just around the corner, starting this Friday!. @urotoday with full coverage: A sample of the excellent research to presented this week πŸ‘‡. @asco @WallisCJD
Tweet media one
0
18
51
@zklaassen_md
Zach Klaassen
2 years
Proud of my man @WallisCJD -- @SUO_YUO paper of the year. @JAMAOnc Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer. @urotoday.@SUO_YUO #SUO22
Tweet media one
Tweet media two
1
10
52
@zklaassen_md
Zach Klaassen
3 years
🚨Impressive results: Ph3 BCG + IL-15RΞ±Fc superagonist N-803 in BCG-unresp NMIBC. @UroCancerMD et al. #GU22 . CIS Cohort.♦️ CR rate: 71%.♦️12-mo CR rate: 62%.♦️24-mo CR rate: 52%. Papillary Cohort.♦️12-mo DF rate: 57%.♦️18-mo DF rate: 53%. Very favorable safety profile.@urotoday
Tweet media one
Tweet media two
Tweet media three
3
22
49
@zklaassen_md
Zach Klaassen
2 years
How to Best Use Current Drugs: Treatment Sequencing and Combinations for mCRPC @Silke_Gillessen . Outstanding possible treatment algorithms based on previous therapies received. #GU23 @urotoday
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
22
51
@zklaassen_md
Zach Klaassen
3 years
Final OS analysis 2yr f/u in CheckMate 9ER: Nivo + Cabo v Sun in aRCC.@tompowles1 et al #GU22 . Benefit of Nivo + Cabo:.πŸ“ŒOS: HR 0.70 95%CI 0.55–0.90.πŸ“ŒPFS: HR 0.56 95%CI 0.46–0.68.πŸ“ŒORR: 55.7% v 28.4%.πŸ“Œβ¬†οΈ % β‰₯30% ⬇️ baseline 🎯 lesion (kidney, liver, lung, LN, bone).@urotoday
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
27
49
@zklaassen_md
Zach Klaassen
7 years
Don't "doctor" anybody on the phone when talking to other services, nurses, SW, etc. we know you've worked hard to get to this point and are DYING to say it. But "Hi, I'm Zach from Urology" goes a long way. We know you're a doctor, trust us.#TipsForNewDocs.
1
12
47
@zklaassen_md
Zach Klaassen
1 year
Timing of RT After RP: Final Results of RADICALS RT #ESMO23 @urotoday . ♦️1,396 pts: 697 adj RT, 699 obs + sRT; mFU 8 yrs.♦️FFDM @ 10 yrs: 92.7% adj RT vs 89.6% obs + sRT (HR 0.68, 95%CI 0.43-1.07).♦️OS @ 10 yrs: was 87.6% adj RT vs 874% obs + sRT (HR 0.98, 95%CI 0.67-1.44)
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
28
51
@zklaassen_md
Zach Klaassen
5 years
AE profile for IO agents vs chemo in solid organ tumors: A SR and MA of RCTs - @Annals_Oncology. Take 🏠:.- 10,598 abstracts screened, 22 RCTs included, 12,727 pts: 16.5% IO AE>=3 vs 41.1% chemo. Great work @d_magee22.& @AHirdMD (future @UroOnc fellows).
Tweet media one
0
26
48
@zklaassen_md
Zach Klaassen
4 years
Great contemporary summary table from Tilman Todenhofer for where we currently are for BCG unresponsive NMIBC. Highly unmet need!.@urotoday #SIU2020
Tweet media one
2
20
49
@zklaassen_md
Zach Klaassen
6 years
First pop-level study accounting for psych comorbidities prior to #Cancer dx - confirming a cancer dx increases suicide risk compared to the gen pop, specifically in first 50 mos (60% ⬆️) @JournalCancer. Many thanks to @GSK_UofT @WallisCJD @KurdyakP et al.
Tweet media one
1
16
47
@zklaassen_md
Zach Klaassen
8 months
#ASCO24 . PSMAfore: the latest RLT therapy in #prostatecancer to show improved HRQoL and improved pain control. @Cpaller @urotoday
Tweet media one
0
22
50
@zklaassen_md
Zach Klaassen
10 months
#EAU24 .The incredible PEACE-6 platform of European trials in mHSPC (Fizazi). Important treatment escalation (Lu-PSMA, in poor PSA responders) and de-escalation (PSA responders 6-8 months) arms of the platform.@urotoday
Tweet media one
1
18
48
@zklaassen_md
Zach Klaassen
5 months
⚑️ LBA ⚑️- ARANOTE: Efficacy & safety of Daro + ADT in mHSPC @urotoday #ESMO24 @BayerOncMed . Daro + ADT vs PBO + ADT:. πŸ“Œn=669; 446 Daro vs 223 PBO.πŸ“ŒPrim EP, rPFS: HR 0.54, 95% CI 0.41–0.71.πŸ“ŒOS: HR 0.81, 95% CI 0.59–1.12.πŸ“ŒTT CRPC: HR 0.40, 95% CI 0.32–0.51.πŸ“ŒTT PSA Prog: HR
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
23
49
@zklaassen_md
Zach Klaassen
2 years
Nice paper in @urogoldjournal, good info. @MCG_AUG with the 4th highest (n = 29) absolute number of med students entering Urology and graduating from @AmerUrological residency programs from 2016-2021.
@rwjurology
Rutgers RWJ Urology
2 years
Just out @urogoldjournal-Characteristics of Medical Schools in US Associated w Successful Match into Urology Residency Programs-Analysis of 2016-2021 Resident Cohort @julianakim04 @isaackimjr @eric_facs @DrDaniVelez @saumyg @TomJangUroOnc #UroSoMe @UroAcademic @AmerUrological πŸ‘‡.
2
8
46
@zklaassen_md
Zach Klaassen
2 years
πŸŽ† Finally here! πŸŽ† @urotoday. Prostate Cancer Patient Voices:. An incredible resource for patients: A one stop shop of patient testimonials and written articles explaining the #prostatecancer journey at the patient level. A huge thank you to my patients
Tweet media one
3
18
46
@zklaassen_md
Zach Klaassen
10 months
#EAU24 PEACE V-STORM: Ph 2 RCT of salvage MDT + 6 mo ADT +/- ENRT for Oligorecurrent nodal PCa: 24-mo toxicity results @ZilliThomas .@urotoday . n=97, MDT vs n=93, ENRT.πŸ“ŒWorst late Gr β‰₯ 2 GI AEs: 5.3% vs 6.6% (p=0.94).πŸ“ŒWorst late GU β‰₯ 2 GU AEs: 22.2% vs 26.5% (p=0.61)
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
21
48
@zklaassen_md
Zach Klaassen
4 years
Every surgeon has a "coffin in the recesses of their brain" that we carry with us for pts that pass post operatively . Make sure you have a colleague to talk to/grieve with about these patients . We learn, move on, help others, but we carry a piece of them forever .#medtwitter.
2
3
48
@zklaassen_md
Zach Klaassen
9 months
#AUA24 @yawnyame State-of-the-Art Lecture: Prostate Cancer Screening High-risk Groups. New @PCFnews Screening Guidelines for Black Men in πŸ‡ΊπŸ‡Έ. Guideline statements πŸ‘‡ @NEJMEvidence @urotoday
Tweet media one
3
17
48
@zklaassen_md
Zach Klaassen
5 years
Example of how fast the 1L combination treatment landscape for RCC is changing: slide below, great summary as of Feb 14, 2020. As of Feb 15, 2020 morning, slide out of date - 42 month update of CheckMate 214 now available. #GU20 .@urotoday
Tweet media one
2
28
46
@zklaassen_md
Zach Klaassen
5 months
#ESMO24 Congress Highlights - Prostate Cancer @UrsulaVogl . Randomized Phase 2/3 trials investigating metformin in prostate cancer. @urotoday
Tweet media one
1
23
44
@zklaassen_md
Zach Klaassen
4 years
Had a lot of fun being co-guest editor with @WallisCJD for the Mental Health in Urology issue of @EurUrolFocus .Important topic and great contributions from @daviesbj @qdtrinh @gorejohn @crisbergerot @montypal @Drkelvinmoses06 @yawnyame @DrShariat @siemensr @CaPsurvivorship et al
Tweet media one
2
8
47
@zklaassen_md
Zach Klaassen
4 years
We will not be using @SignalTokens here at @mcg_urology . As PD, all applications are reviewed in detail -- if you are invited to an interview, we think you have the potential to be a resident at our program. We hope this alleviates anxiety during this challenging year.
@Uro_Res
The Urology Applicant βš•
4 years
.@UroAcademic please consider making an official statement on @SignalTokens and related entities. although many PD’s have indicated that they will not be participating, applicants are still apprehensive and may buy-in out of an abundance of caution . @UroResidency @Uro_Stream.
0
7
44
@zklaassen_md
Zach Klaassen
7 years
Forever indebted to my wife @urowife_designs family, friends and the hundreds of folks along the way that have shaped my career over the last 17 year's of school and training. The end of the beginning @goUFV @SFU @StGeorgesU @SaintBarnabasNJ @mcg_urology @UofTUrology @ihpmeuoft.
5
3
44
@zklaassen_md
Zach Klaassen
2 months
#SUO24 Bladder Cancer Course - Emerging Perioperative Systemic Therapy @jackiebrown_MD . Summary of adjuvant immunotherapy monotherapy phase 3 trials. @urotoday
Tweet media one
1
26
52
@zklaassen_md
Zach Klaassen
2 years
For those (like me) having trouble keeping up with the timeline of FDA movement in the 1L mUC setting for CPIs, great summary from @apolo_andrea in #GU23 discussion .πŸ”‘ 4/21: Atezo keeps indication.πŸ”‘ 8/21: Remove pembro indication for cis-ineligible PD-L1 ⬆️; cont for
Tweet media one
0
16
46
@zklaassen_md
Zach Klaassen
6 years
If you find Gleason 6 #prostatecancer in men >70 years of age, please ONLY offer active surveillance:.1) It's the right thing for the patient.2) It'll save Medicare ~$320 million.@corp_UNC @JAMAOnc.
2
12
40
@zklaassen_md
Zach Klaassen
3 years
A picture worth a thousand words: dramatic decrease in VHL lesions after Belzutifan from Dr. Jodi Maranchie. Trial published last week in @NEJM : @urotoday #SUO21
Tweet media one
1
7
43
@zklaassen_md
Zach Klaassen
4 years
2020 Phrase of the Year. "Can you see my screen?".
3
2
40
@zklaassen_md
Zach Klaassen
3 years
Phenomenal weekend having @FleshnerNeil down to Augusta as our keynote speaker for the 48th annual Rinker-Witherington Urologic Symposium . Keeping the Toronto-Augusta connection strong: @rksayyid heading north next year for @UroOnc fellowship
Tweet media one
1
1
43
@zklaassen_md
Zach Klaassen
3 years
Discussing starting active surveillance with a patient in clinic today for low volume GG1 #prostatecancer . "Doc, so what your saying is: the house ain't on fire, but we have the fire extinguisher near by". EXACTLY.
1
2
43
@zklaassen_md
Zach Klaassen
4 years
We're excited to get the band back together for another set of @mcg_urology virtual open houses this summer leading into Fall's interview season. Mark your πŸ“†!. Thurs, July 15: 7PM EST.Sat, Aug 21: 1PM EST.Sat, Sept 18: 1PM EST. @Uro_Res @UroAcademic @MCG_AUG . Details to follow.
0
8
43
@zklaassen_md
Zach Klaassen
5 years
This is what happens when TSA kindly tells you at airport security that your driver's license expired 4 days ago (had no idea) and you get to rock #movember every day for the next 5 years on your new licenseπŸ”₯πŸ”₯ Don't forget to donate to our Movember team. for the next 5 yrs
Tweet media one
2
2
42
@zklaassen_md
Zach Klaassen
9 months
#APCCC24 @Tilki_De summarizing the ongoing trials for patients with PSA persistence after definitive local therapy.@urotoday
Tweet media one
1
21
43
@zklaassen_md
Zach Klaassen
4 years
Surgeons waiting for the a-line to be placed.#MedTwitter #anesthesia
Tweet media one
3
2
43
@zklaassen_md
Zach Klaassen
5 years
So proud of our @MCG_AUG medical students in today's @AmerUrological #uromatch . 8 out of 9 matched!. Incredibly proud that 2 will be joining @mcg_urology too πŸ™ŒπŸ». @AUG_Health @MCG_Surgery.
2
6
42
@zklaassen_md
Zach Klaassen
9 months
#AUA24 @UrogerliMD MoonRISe-1: Ph 3 study of TAR-210 vs intravesical chemo in pts with IR NMIBC with susceptible FGFR alt @urotoday . πŸ“n=540, randomized 1:1 to TAR-210 vs choice of intravesical chemotherapy (MMC or Gem).πŸ“1L EP: DFS.πŸ“Enrollment opened April 10, 2024: planned at
Tweet media one
Tweet media two
Tweet media three
0
9
41
@zklaassen_md
Zach Klaassen
3 years
Excellent summary of the current landscape in June 2022 for metastatic urothelial carcinoma . @shilpaonc discussant presentation today during the kidney/bladder oral abstract session -- awaiting results of EV302 (EV + pembro in 1L treatment). @urotoday #ASCO22
Tweet media one
3
13
42
@zklaassen_md
Zach Klaassen
3 years
So excited for these phenomenal new urologists joining us at @mcg_urology πŸ₯‚πŸ». Congratulations and welcome to Chen Jiang, @EdwardMachen7 and @Drewology!. #AUAMatch.
@mcg_urology
MCG Urology
3 years
So thrilled to have matched these amazing future urologists!
Tweet media one
0
4
39
@zklaassen_md
Zach Klaassen
1 year
Brilliant RCC discussant in oral abstracts for RCC by @PBarataMD . Summary of the phase 3 adjuvant ICI RCTs in RCC. #GU24 @urotoday
Tweet media one
2
24
41
@zklaassen_md
Zach Klaassen
3 years
Evidence of 'triplet therapy' (ADT + doce + additional systemic Rx) in mHSPC from @Prof_IanD #APCCC21. Best evidence in ENZAMET (ADT + doce + enza): no OS benefit yet (50% of events), but strong PFS signal for triplet. @urotoday @APCCC_Lugano @ANZUPtrials.
Tweet media one
Tweet media two
0
12
40
@zklaassen_md
Zach Klaassen
4 months
Undetectable ctDNA Before RC Predicts πŸ”Ό Outcomes @urotoday #IBCN2024 @DrJohnSfakianos @IBCN1997 . πŸ‡¨πŸ‡­n=134.πŸ‡¨πŸ‡­n=85 (63.4%) pts had MIBC, 25 (29.4%) had NAC .- Med F/U 10 mos: 40 (29.9%) pts had dx relapse.πŸ‡¨πŸ‡­Undetect vs Detect ctDNA, 12 mo RFS rate: 93% vs 40%.πŸ‡¨πŸ‡­Undetect ctDNA: πŸ”Ό
Tweet media one
Tweet media two
Tweet media three
1
11
41
@zklaassen_md
Zach Klaassen
5 years
1-line Treatment of mRCC: A Systematic Review and NMA. ITT pop:.PFS - Cabo (SUCRA 84%), avelumab + axi (SUCRA 68%), pembro + axi (SUCRA 82%).OS - Pembro + axi (SUCRA 95%).Lower AEs - Atezo (SUCRA 100%). Similar for int/poor risk pts. @EurUrolOncol.
Tweet media one
Tweet media two
1
25
39
@zklaassen_md
Zach Klaassen
2 years
ADT and risk of dementia in pts w/ #ProstateCancer . πŸ“Œ 627,025 ADT PS-match to 73,933 no ADT.πŸ“Œ ADT: assoc w/ dementia: HR 1.60, 95%CI 1.49, 1.73.πŸ“Œ ADT: inc risk of dementia White men (78.6% vs 77.7%, p<0.001); no diff AA men.πŸ“Œ Highest risk: GnRH antag (HR 1.92, 95%CI
Tweet media one
Tweet media two
3
17
38
@zklaassen_md
Zach Klaassen
11 months
Decades of progress in 1L clear cell mRCC treatment @DrRanaMcKay . From an OS benefit of 10 mos in 1992 (cytokine era) to 56 mos in 2018 (ICB + targeted therapy). @urotoday #SoCalGU24
Tweet media one
0
17
41
@zklaassen_md
Zach Klaassen
6 years
Giving a presentation "What is Urology?" to my daughter's 5th grade Horizons class tomorrow. Other than focusing on stones rather than penile/testis cancer, any other words of wisdom from #UroSoMe ? Prop ideas (no IPPs)?.πŸ˜³πŸ™ƒ.
10
2
40
@zklaassen_md
Zach Klaassen
3 years
Missed #GU22 @ASCO ?. Check out the 309 talk summaries posted @urotoday - @WallisCJD @DrJonesNauseef @aloktewar @jberchuck.
1
9
41
@zklaassen_md
Zach Klaassen
4 years
I know we all have these from grateful patients, but there's something about a hand written note from a patient (17 cm renal mass s/p nephrectomy) in your mail box after a long clinic day.πŸ™πŸ™ #KidneyCancerAwarenessMonth
Tweet media one
2
0
39
@zklaassen_md
Zach Klaassen
5 years
Amen @UroDocAsh . Was told by my med school to not bother applying to #urology because "you won't have a chance" (despite 256/264 USMLE 1/2 and 25 pubs). Forever grateful to @mcg_urology , @mkterris , and Dr. Ron Lewis for taking a flier on an IMG from πŸ‡¨πŸ‡¦.πŸ™.
@UroDocAsh
Ashish M. Kamat, MD, MBBS
5 years
#ThisIsReal.Lost track of the number of times I was told to β€˜not bother’ when applying for residency as an #IMG . But remember - and will be eternally grateful to - the two (Don Lamm and Stan Kandzari) who said β€˜we will take a chance on you’.
4
4
41
@zklaassen_md
Zach Klaassen
5 years
Algorithm from Dr. Morey @UTSWUrology for calculating level of resident involvement in a case πŸ‘πŸΌπŸ‘πŸΌ.Cc: @UroOncMD .#SAU2020
Tweet media one
2
4
39
@zklaassen_md
Zach Klaassen
3 years
Contagious Enthusiasm in PSMA-Driven Therapeutics by @EfstathiouEleni #APCCC21. πŸ“177Lu-PSMA trials earlier in the disease. Stay tuned for upcoming:.πŸ“PSMA-targeted bispecific T-cell engager (BiTE) immunother.πŸ“PSMA-targeted CAR-T. @urotoday @APCCC_Lugano.
Tweet media one
0
14
41
@zklaassen_md
Zach Klaassen
3 years
At @mcg_urology mentorship is like recruiting for big time College Football programs: year round. Zoom call today with the newly matched M4s discussing their experience with the M3s applying next year #AUAMatch . More excellent @MCG_AUG Urology candidates coming next year!
Tweet media one
1
3
40